{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:55Z","timestamp":1707525595570},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,16]]},"DOI":"10.7759\/cureus.50621","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T13:44:36Z","timestamp":1702734276000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Chronic Eosinophilic Pneumonia Associated With the Use of Weight Loss Combination Medication Naltrexone-Bupropion"],"prefix":"10.7759","author":[{"given":"Anastasia","family":"Schuldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Najmuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Surani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Chronic eosinophilic pneumonia. (2023). https.\/\/medilib.ir\/uptodate\/show\/4360."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819cc502","article-title":"Acute eosinophilic pneumonia: a case report and review of the literature","volume":"37","author":"Janz DR","year":"2009","unstructured":"Janz DR, O'Neal HR Jr, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med. 2009, 37:1470-4. 10.1097\/CCM.0b013e31819cc502","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt JC","year":"2005","unstructured":"Garbutt JC, Kranzler HR, O'Malley SS, et al.. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005, 293:1617-25. 10.1001\/jama.293.13.1617","journal-title":"JAMA"},{"key":"ref4","article-title":"Eosinophilic pneumonia induced by injectable naltrexone","volume":"189","author":"Kim H","year":"2014","unstructured":"Kim H, Ali M, Buch K. Eosinophilic pneumonia induced by injectable naltrexone. Am J Respir Crit Care Med. 2014, 189:A2283.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-013-9803-y","article-title":"Eosinophilia associated with bupropion","volume":"35","author":"Garc\u00eda M","year":"2013","unstructured":"Garc\u00eda M, Ruiz B, Aguirre C, Etxegarai E, Lertxundi U. Eosinophilia associated with bupropion. Int J Clin Pharm. 2013, 35:532-4. 10.1007\/s11096-013-9803-y","journal-title":"Int J Clin Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2112056","article-title":"Idiopathic acute eosinophilic pneumonia: a study of 22 patients","volume":"166","author":"Philit F","year":"2002","unstructured":"Philit F, Etienne-Mastro\u00efanni B, Parrot A, Gu\u00e9rin C, Robert D, Cordier JF. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002, 166:1235-9. 10.1164\/rccm.2112056","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2669","article-title":"Alterations in smoking habits are associated with acute eosinophilic pneumonia","volume":"133","author":"Uchiyama H","year":"2008","unstructured":"Uchiyama H, Suda T, Nakamura Y, et al.. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest. 2008, 133:1174-80. 10.1378\/chest.07-2669","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1286","article-title":"Ceftaroline-induced eosinophilic pneumonia","volume":"33","author":"Desai KR","year":"2013","unstructured":"Desai KR, Burdette SD, Polenakovik HM, Hagaman J, Pleiman CM. Ceftaroline-induced eosinophilic pneumonia. Pharmacotherapy. 2013, 33:e166-9. 10.1002\/phar.1286","journal-title":"Pharmacotherapy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10221","article-title":"A case for biopsy: injectable naltrexone-induced acute eosinophilic pneumonia","volume":"12","author":"Korpole PR","year":"2020","unstructured":"Korpole PR, Al-Bacha S, Hamadeh S. A case for biopsy: injectable naltrexone-induced acute eosinophilic pneumonia. Cureus. 2020, 12:e10221. 10.7759\/cureus.10221","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.08.2138","article-title":"Saved by the BAL: a case of acute eosinophilic pneumonia after methyl-naltrexone injection","volume":"156","author":"Esposito A","year":"2019","unstructured":"Esposito A, Lau B. Saved by the BAL: a case of acute eosinophilic pneumonia after methyl-naltrexone injection. Chest. 2019, 156:2210. 10.1016\/j.chest.2019.08.2138","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.08.917","article-title":"Chronic eosinophilic pneumonia: adjunctive therapy with inhaled steroids","volume":"150","author":"Chan C","year":"2016","unstructured":"Chan C, DeLapp D, Nystrom P. Chronic eosinophilic pneumonia: adjunctive therapy with inhaled steroids. Chest. 2016, 150:821A. 10.1016\/j.chest.2016.08.917","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2035","article-title":"Can omalizumab be effective in chronic eosinophilic pneumonia?","volume":"143","author":"Domingo C","year":"2013","unstructured":"Domingo C, Pomares X. Can omalizumab be effective in chronic eosinophilic pneumonia?. Chest. 2013, 143:274-5. 10.1378\/chest.12-2035","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1881","article-title":"Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia","volume":"142","author":"Kaya H","year":"2012","unstructured":"Kaya H, G\u00fcm\u00fc\u015f S, U\u00e7ar E, Aydo\u011fan M, Mu\u015fabak U, Tozkoparan E, Bilgi\u00e7 H. Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia. Chest. 2012, 142:513-16. 10.1378\/chest.11-1881","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2012.27.10.1261","article-title":"Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy","volume":"27","author":"Shin YS","year":"2012","unstructured":"Shin YS, Jin HJ, Yoo HS, Hwang EK, Nam YH, Ye YM, Park HS. Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy. J Korean Med Sci. 2012, 27:1261-4. 10.3346\/jkms.2012.27.10.1261","journal-title":"J Korean Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(01)00159-5","article-title":"Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival","volume":"14","author":"Kalesnikoff J","year":"2001","unstructured":"Kalesnikoff J, Huber M, Lam V, Darnen J, Zhang J, Slraganian R, Krystal G. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 2001, 14:801-11. 10.1016\/s1074-7613(01)00159-5","journal-title":"Immunity"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/202116-a-case-of-chronic-eosinophilic-pneumonia-associated-with-the-use-of-weight-loss-combination-medication-naltrexone-bupropion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:42Z","timestamp":1707509382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/202116-a-case-of-chronic-eosinophilic-pneumonia-associated-with-the-use-of-weight-loss-combination-medication-naltrexone-bupropion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.50621","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,16]]}}}